• Obstetrics - high-risk pregnancy, labor management, complications, fetal monitoring
• Gynaecology - benign and malignant conditions, surgical procedures, endocrinology
• Pharmacology - drugs in pregnancy, tocolytics, oxytocics, hormonal therapies
• Clinical scenarios - case-based reasoning, differentials, management protocols
• Exam prep - conceptual questions, guidelines, evidence-based medicine

• Obstetrics questions → answered from Williams Obstetrics
• Gynaecology questions → answered from Berek & Novak's Gynecology

• Obstetrics → Williams Obstetrics
• Gynaecology → Berek & Novak's Gynecology

Mature Teratoma (Dermoid Cyst)

Classification

• Biphasic or Triphasic Teratoma
  • Immature teratoma
  • Mature teratoma
    • Solid
    • Cystic
      • Dermoid cyst (the most common form)
      • Fetiform teratoma (homunculus)
  • Monodermal teratomas and somatic-type tumors arising from dermoid cysts (e.g., struma ovarii, carcinoid, neuroectodermal tumors)

Pathology and Maturation

"If maturation continues along normal lines, it results in a mature teratoma, and the prognosis is excellent as these are benign tumors with the rare exception of other tumors arising from mature elements, such as squamous cell carcinomas. Conversely, abnormal maturation of these elements can result in an immature teratoma that has metastatic potential."

• Berek & Novak's Gynecology, Pathology and Grading

• Ectoderm: skin, hair follicles, sebaceous glands, neural tissue
• Mesoderm: fat, muscle, bone, cartilage
• Endoderm: respiratory/GI epithelium, thyroid tissue

Mature Cystic Teratoma (Dermoid Cyst) - Clinical Features

• Most common ovarian germ cell tumor and most common benign ovarian tumor in women of reproductive age
• Bilateral in approximately 10% of cases
• Typically anterior in location on pelvic examination (due to fatty/sebaceous content making it buoyant)
• Contains teeth, hair, sebaceous material - visible on plain X-ray or ultrasound
• Can grow to large dimensions

FIGURE 10-3: Mature cystic teratoma (dermoid cyst) of the ovary - Berek & Novak's Gynecology

Tumor Markers

Complications

1. Torsion - most common complication, due to the weight and anterior position
2. Rupture - can cause chemical/granulomatous peritonitis from sebaceous spillage
3. Malignant transformation - rare (~1-2%), most commonly squamous cell carcinoma arising from mature elements
4. Pseudomyxoma peritonei - rarely, if mucinous elements are present
5. Malignant melanoma - can arise rarely in a mature cystic teratoma

Monodermal Variants

• Struma ovarii - thyroid tissue predominates; can cause hyperthyroidism
• Ovarian carcinoid - functioning carcinoid tissue; can cause carcinoid syndrome
• Neuroectodermal tumor - rare

Management

• Reproductive-age women: Cystectomy (ovarian-sparing surgery) is preferred to preserve fertility
• Postmenopausal women: Oophorectomy acceptable
• Caution at surgery: Avoid intraperitoneal spillage of contents (sebaceous material causes granulomatous peritonitis), though some evidence suggests spillage alone does not always lead to peritonitis if properly irrigated
• Bilateral disease: Contralateral ovary need not be bivalved routinely given the low yield and surgical risk
• No adjuvant chemotherapy needed - purely surgical management for benign disease

Key Points to Remember

• Berek & Novak's Gynecology, Chapter 39 - Germ Cell Malignancies; Chapter 10 - Neoplastic Masses

Mature vs. Immature Teratoma - A Complete Comparison

The Fundamental Concept

"If maturation continues along normal lines, it results in a mature teratoma, and the prognosis is excellent as these are benign tumors... Conversely, abnormal maturation of these elements can result in an immature teratoma that has metastatic potential."

• Berek & Novak's Gynecology, Ch. 39

Side-by-Side Comparison Table

Grading of Immature Teratoma

Note: The current preferred system is a two-tier system (low grade vs. high grade) due to significant inter- and intraobserver difficulty with the three-tier system.

Histology

FIGURE 39-21: Ovarian teratoma with both mature and immature neural elements - the dark dense cluster (center) represents the immature neural tube-like structure. - Berek & Novak's Gynecology

Treatment Differences

Mature Teratoma

• Cystectomy - conserve the ovary
• No chemotherapy
• Watch for complications (torsion, malignant transformation)

Immature Teratoma

• Unilateral oophorectomy + fertility-sparing staging (premenopausal)
• Stage IA, Grade 1 → surgery alone (surveillance), no adjuvant therapy
• Stage IA, high grade → adjuvant BEP chemotherapy (3 cycles)
• Stage IC and above → BEP (3 cycles if completely resected, 4 cycles if macroscopic residual)
• Treatment should start within 7-10 days of surgery (these tumors can progress rapidly)

Special Point: Gliomatosis Peritonei

Malignant Transformation in Mature Teratoma

• Berek & Novak's Gynecology, Chapter 39

Subtypes of Mature Teratoma - From Berek & Novak's Gynecology

WHO Classification Recap (Table 39-5, Berek & Novak)

Mature Teratoma
├── 1. Solid mature teratoma
└── 2. Cystic mature teratoma
    ├── a. Dermoid cyst  ← most common
    └── b. Fetiform teratoma (Homunculus)

Monodermal Teratoma (separate category)
├── Struma ovarii (thyroid)
├── Carcinoid
├── Neuroectodermal tumor
├── Carcinoma
├── Melanocytic
├── Sarcoma
├── Sebaceous tumor
├── Pituitary-type tumor
└── Others

Comparison Table

1. Mature Solid Teratoma

• Contains all three germ layers but in a solid (non-cystic) arrangement
• No predominant cyst cavity; tissue is compacted
• Contains a mix of mature adipose, neural tissue, cartilage, bone, epithelium
• Rare - most mature teratomas are cystic
• Clinically benign; managed with surgical excision
• On imaging: solid ovarian mass without the classic fat-fluid level of a dermoid

2. Mature Cystic Teratoma (Dermoid Cyst)

• The most common ovarian germ cell tumor
• Cystic cavity lined by skin-like epithelium filled with sebaceous material, hair, teeth
• Contains Rokitansky protuberance (dermoid plug / mamillary body) - a nodule projecting into the cyst where most solid tissue elements concentrate
• 10% bilateral
• Located anteriorly (fat content makes it buoyant)
• Teeth/calcification visible on plain X-ray
• Malignant transformation in 0.5-2% (squamous cell carcinoma most common)
• Treatment: Cystectomy (fertility-sparing)

3. Fetiform Teratoma (Homunculus)

• An extremely rare variant of mature cystic teratoma
• Contains a fetus-like structure within the ovarian cyst - with recognizable axial organization, limb buds, and rudimentary organ structures
• Represents the most extreme degree of differentiation and organogenesis within a teratoma
• All tissues are fully mature - this is NOT a fetus and is NOT related to a twin (no placenta, no umbilical cord, no genetic material from a father)
• Arises from a single parthenogenetic cell (46,XX genotype)
• Distinguished from fetus in fetu (which is a parasitic twin, located retroperitoneally, has a vertebral axis, own blood supply)
• Clinically benign; treatment is surgical excision

4. Monodermal Teratoma

• Unlike the above three (which contain all 3 germ layers), monodermal teratomas are composed predominantly or exclusively of ONE tissue type
• They still arise from germ cells but differentiation is channeled into a single lineage
• Listed as a separate WHO category from biphasic/triphasic teratomas

Key Monodermal Types:

a. Struma Ovarii (Most Common)

• Composed predominantly of thyroid tissue
• Can cause hyperthyroidism (thyrotoxicosis) - listed in Berek & Novak's as a rare cause of thyrotoxicosis
• Radioiodine uptake will be suppressed in the neck (thyroid tissue is in the pelvis)
• Malignant struma ovarii (follicular or papillary thyroid carcinoma) occurs rarely
• Treatment: Surgical resection; malignant form may need radioiodine

b. Ovarian Carcinoid

• Composed of neuroendocrine (carcinoid) tissue
• Primary ovarian carcinoids (arising de novo in a teratoma) - distinguished from metastatic carcinoid to the ovary
• Can produce serotonin and cause carcinoid syndrome (flushing, diarrhea, bronchospasm) - notable because primary ovarian carcinoids drain directly into the systemic circulation, bypassing the portal/liver, so carcinoid syndrome can occur even without liver metastases
• Treatment: Surgical excision; oophorectomy usually curative

c. Neuroectodermal Tumor

• Composed of neural tissue
• Rare; treated like primary CNS tumors

d. Sebaceous Tumor, Pituitary-type, Melanocytic

• Extremely rare; represent tissue-specific overgrowth within a teratoma

Key Summary Point

The fundamental concept: mature teratoma subtypes differ in HOW their well-differentiated tissues are organized (solid vs. cystic vs. fetus-like vs. single-tissue). Monodermal teratomas are distinguished by having only one germ layer/tissue type dominate, and they can be functionally active (struma ovarii causing hyperthyroidism; carcinoid causing carcinoid syndrome) - a feature absent in the other subtypes.

• Berek & Novak's Gynecology, Chapter 39 - WHO Classification Table 39-5; Germ Cell Malignancies

Role of Betamethasone (Betnasol) After 34 Weeks of Pregnancy

Note: Williams Obstetrics is not available in the library. This answer is from Creasy & Resnik's Maternal-Fetal Medicine (the equivalent authoritative MFM text) supplemented by landmark trial evidence.

Background - Classical Teaching (Before 34 Weeks)

• Reduces RDS (respiratory distress syndrome)
• Reduces IVH (intraventricular hemorrhage)
• Reduces neonatal death
• Regimen: Betamethasone 12 mg IM x 2 doses, 24 hours apart

The Key Question: Does Betamethasone Have a Role at 34-36+6 Weeks (Late Preterm Period)?

YES - This is the "Late Preterm" Indication

• Population: Women at risk of late preterm delivery (34+0 to 36+6 weeks)
• Intervention: Betamethasone 12 mg IM x 2 doses vs. placebo
• Key findings:
  • Reduced primary composite respiratory outcome (need for CPAP, high-flow O2, surfactant, mechanical ventilation, ECMO, or death)
  • Reduced transient tachypnoea of the newborn (TTN)
  • Reduced RDS
  • Reduced need for resuscitation at birth
• Caveat: Increased rate of neonatal hypoglycaemia in the betamethasone group

"Based on the results of recent studies of antenatal steroid administration for anticipated late preterm birth, antenatal steroid administration should also be considered if conservative management is pursued at 34 to 36 weeks' gestation."

Long-Term Safety (ALPS Follow-Up Study, JAMA 2024)

• No adverse neurodevelopmental outcomes (General Conceptual Ability scores were similar between betamethasone and placebo groups)
• No differences in gross motor function, social responsiveness, or behavioural outcomes
• The neonatal hypoglycaemia observed remained the primary concern but did not translate into long-term harm

Current Guidelines Summary

Important Conditions for Late Preterm (34-36+6 wks) Use

1. No prior course of ACS given (betamethasone is not recommended if the patient already received a course earlier in pregnancy)
2. Singleton pregnancy (original ALPS trial was in singletons; 2025 RCT from JAMA Pediatrics now supports use in twins as well - PMID 40982289)
3. Delivery anticipated within 7 days
4. No maternal diabetes - use with caution as betamethasone causes significant transient hyperglycaemia and neonatal hypoglycaemia

Beyond 36+6 Weeks (≥ 37 weeks)

• Elective caesarean section at term - some studies suggest betamethasone 48 hours before elective CS may reduce TTN, but this is not standard of care and not currently endorsed by ACOG/SMFM/RCOG as routine practice

Key Takeaway

Yes, betamethasone has a well-established role at 34+0 to 36+6 weeks (late preterm) to reduce neonatal respiratory morbidity, supported by the ALPS trial. It is not recommended after 37 weeks as routine practice. The main risk at this gestational age is neonatal hypoglycaemia, and long-term neurodevelopmental follow-up has been reassuring.

• Creasy & Resnik's Maternal-Fetal Medicine, Chapter on Preterm PROM, block9 lines 1887-1891
• Gyamfi-Bannerman C et al., NEJM 2016 (ALPS Trial) - referenced in Creasy & Resnik
• ALPS Follow-Up Study, JAMA 2024 [PMID 38656759]